Oral Abstract Presentation Session 2
Tracks
.
| Thursday, October 2, 2025 |
| 1:45 PM - 4:00 PM |
| Room 14 |
Overview
Chairs:
Natasha Archer & Enrico Novelli
Presenters
Dr. Natasha Archer
Director Of Sickle Cell Program
Boston Children's Hospital
Session Chair
Prof. Enrico Novelli
Chief, Division of Classical Hematology, Director, UPMC Adult Sickle Cell Program, University of Pittsburgh
University of Pittsburgh
Session Chair
Mr Alexandros Abdel Massih
Phd Student
King's College London
In Utero Gene Editing Tools for Sickle Cell Disease
Dr. Farhan Ali Anjum
Consultant Haematologist, Lead gene Therapy
Manchester University Foundation Trust
Gene Therapy in Transfusion-Dependant Beta Thalassaemia. Single Centre Experience: Manchester University Hospitals.
Dr. Anne Charrier
Cnrs Researcher
Cnrs - Aix-marseille Université
Red blood cell movement under flow: a new marker of deformability for SCD patients
Miss Lisa Joy Kaiser
Phd Student
Kings College London
Nanoparticle Engineering for the Prenatal Therapy of Sickle Cell Disease
Prof. Thomas Klingebiel
Professor Emeritus
Goethe University Frankfurt
A COST-CONSCIOUS AND HIGHLY SUCCESFUL START-UP STRATEGY FOR HEMATOPOIETIC CELL TRANSPLANTATION IN MIDDLE-INCOME COUNTRIES
Ms Alexis Wilkinson
Graduate Student
Rice University
SCD-RPA: a point-of-care friendly genetic test for diagnosing SCD from buccal swab samples without extraction
Prof. Sujit Sheth
Chief of the Division of Pediatric Hematology/Oncology
New York-Presbyterian Hospital-Weill Cornell Medical Center
Real-world safety profile of twice-daily deferiprone for iron overload in patients with sickle cell disease
Dr Eva Tsouana
Consultant Paediatrician
Mid And South Essex NHS Trust
Mind the Gap: A 10-year audit of emergency pain management in transition-age sickle cell patients
Dr Rana Zareef
Pediatric Cardiology Fellow
American University of Beirut Medical Center
Left Ventricular Mechanics in Pediatric Sickle Cell Disease: Analysis of Strain and Chamber Dimensions
